This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Pal, B. Articles by Diffey, B. Search for Related Content PubMed Articles by Pal, B. Articles by Diffey, B. Social Bookmarking                   What's this?

Should diuretics be prescribed for idiopathic carpal tunnel syndrome? Results of a controlled trial

Department of Rheumatology Dryburn Hospital

P. Mangion

Department of Rheumatology Dryburn Hospital

MA Hossain

Department of Rheumatology Dryburn Hospital

AS Wallace

Department of Rheumatology Dryburn Hospital

BL Diffey

Department of Medical Physics, Dryburn Hospital, Durham

Diuretics are often prescribed to treat carpal tunnel syndrome (CTS) but their beneficial effect is unproven. In this double-blind controlled trial of bendrofluazide given for one month in 48 patients with the idiopathic CTS, treated and control patients showed similar clinical improvement, but the treated group showed more improvement than controls on electrophysiological tests. We conclude that bendrofluazide 5mgm daily for one month does not confer additional clinical benefit in the idiopathic CTS, but further trials with stronger diuretics and/or longer periods of treatment are warranted.

Clinical Rehabilitation, Vol. 2, No. 4, 299-301 (1988)
DOI: 10.1177/026921558800200405


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?